Tangeretin

Tangeretin is a lipid of Polyketides (PK) class. Tangeretin is associated with abnormalities such as Cardiovascular Diseases, Complex Regional Pain Syndromes, Blood Clot, Hypercholesterolemia and Restenosis. The involved functions are known as Thrombus, Platelet function, Localized desquamation, Platelet Activation and Signal. Tangeretin often locates in Protoplasm, Cytoplasmic Granules, Cytoplasmic matrix, Plasma membrane and Blood. The associated genes with Tangeretin are GP6 gene, CDK2 gene, CDK6 gene, Tumor Suppressor Genes and CDH1 gene. The related lipids are Lipopolysaccharides. The related experimental models are Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Tangeretin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tangeretin?

Tangeretin is suspected in Complex Regional Pain Syndromes, Cardiovascular Diseases, Blood Clot, Hypercholesterolemia, Restenosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tangeretin

MeSH term MeSH ID Detail
Diabetes Mellitus D003920 90 associated lipids
Lung Neoplasms D008175 171 associated lipids
Reperfusion Injury D015427 65 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Parkinson Disease D010300 53 associated lipids
Per page 10 20 | Total 13

PubChem Associated disorders and diseases

What pathways are associated with Tangeretin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tangeretin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tangeretin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tangeretin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Tangeretin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tangeretin?

Mouse Model

Mouse Model are used in the study 'Methoxyflavones protect cells against endoplasmic reticulum stress and neurotoxin.' (Takano K et al., 2007) and Mouse Model are used in the study 'Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer.' (Bracke ME et al., 1999).

Transgenic Model

Transgenic Model are used in the study 'Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?' (Walle T, 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tangeretin

Download all related citations
Per page 10 20 50 100 | Total 222
Authors Title Published Journal PubMed Link
Green CO et al. Determination of polymethoxylated flavones in peels of selected Jamaican and Mexican citrus (Citrus spp.) cultivars by high-performance liquid chromatography. 2007 Biomed. Chromatogr. pmid:17080505
Hamada M et al. TCDD-induced CYP1A1 expression, an index of dioxin toxicity, is suppressed by flavonoids permeating the human intestinal Caco-2 cell monolayers. 2006 J. Agric. Food Chem. pmid:17090139
Li LJ et al. [Chemical constituents from roots of Platycodon grandiflorum]. 2006 Zhongguo Zhong Yao Za Zhi pmid:17144467
Ujiki MB et al. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. 2006 Mol. Cancer pmid:17196098
Morley KL et al. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. 2007 Cancer Lett. pmid:17197076
Zhou DY et al. Characterization of polymethoxylated flavones in Fructus aurantii by liquid chromatography with atmospheric pressure chemical ionization combined with tandem mass spectrometry. 2007 J Pharm Biomed Anal pmid:17291708
Mertens-Talcott SU et al. Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells. 2007 J. Agric. Food Chem. pmid:17348674
Wang D et al. Identification of polymethoxylated flavones from green tangerine peel (Pericarpium Citri Reticulatae Viride) by chromatographic and spectroscopic techniques. 2007 J Pharm Biomed Anal pmid:17367982
Yi LZ et al. Quality control and discrimination of pericarpium citri reticulatae and pericarpium citri reticulatae viride based on high-performance liquid chromatographic fingerprints and multivariate statistical analysis. 2007 Anal. Chim. Acta pmid:17386812
Malemud CJ Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways. 2007 Curr Opin Pharmacol pmid:17398158
Choi SY et al. Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. 2007 Biol. Pharm. Bull. pmid:17409518
Fan K et al. Chemopreventive effects of orange peel extract (OPE). I: OPE inhibits intestinal tumor growth in ApcMin/+ mice. 2007 J Med Food pmid:17472461
Abe S et al. Chemopreventive effects of orange peel extract (OPE). II: OPE inhibits atypical hyperplastic lesions in rodent mammary gland. 2007 J Med Food pmid:17472462
Ohtani H et al. Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells. 2007 Pharm. Res. pmid:17492365
Buisson D et al. Biotransformation of polymethoxylated flavonoids: access to their 4'-O-demethylated metabolites. 2007 J. Nat. Prod. pmid:17559266
Walle T Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? 2007 Semin. Cancer Biol. pmid:17574860
Walle UK and Walle T Bioavailable flavonoids: cytochrome P450-mediated metabolism of methoxyflavones. 2007 Drug Metab. Dispos. pmid:17709371
Nishimuta H et al. Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. 2007 Biopharm Drug Dispos pmid:17876860
Johann S et al. Antimicrobial activity of wax and hexane extracts from Citrus spp. peels. 2007 Mem. Inst. Oswaldo Cruz pmid:17923995
Wang Z et al. Validated reversed phase LC method for quantitative analysis of polymethoxyflavones in citrus peel extracts. 2008 J Sep Sci pmid:18095294
Quintieri L et al. Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. 2008 Biochem. Pharmacol. pmid:18191104
Xu GH et al. Minerals, phenolic compounds, and antioxidant capacity of citrus peel extract by hot water. 2008 J. Food Sci. pmid:18211343
Akao Y et al. Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells. 2008 Bioorg. Med. Chem. pmid:18282757
Bracke ME et al. Plant polyphenolics as anti-invasive cancer agents. 2008 Anticancer Agents Med Chem pmid:18288920
Miller EG et al. Inhibition of oral carcinogenesis by citrus flavonoids. 2008 Nutr Cancer pmid:18444138
Satsu H et al. Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals. 2008 J. Agric. Food Chem. pmid:18540626
Ho SC and Lin CC Investigation of heat treating conditions for enhancing the anti-inflammatory activity of citrus fruit (Citrus reticulata) peels. 2008 J. Agric. Food Chem. pmid:18683945
Eguchi A et al. Suppressive effects of demethylated metabolites of nobiletin on phorbol ester-induced expression of scavenger receptor genes in THP-1 human monocytic cells. 2007 Biofactors pmid:18806314
Sekiguchi H et al. Suppressive Effects of Selected Food Phytochemicals on CD74 Expression in NCI-N87 Gastric Carcinoma Cells. 2008 J Clin Biochem Nutr pmid:18818744
Quintin J et al. Synthesis and biological evaluation of a series of tangeretin-derived chalcones. 2009 Bioorg. Med. Chem. Lett. pmid:19013795
Bracke M et al. Effect of catechins and citrus flavonoids on invasion in vitro. 1991 Jan-Feb Clin. Exp. Metastasis pmid:1901781
Zhou DY et al. UPLC/Q-TOFMS/MS as a powerful technique for rapid identification of polymethoxylated flavones in Fructus aurantii. 2009 J Pharm Biomed Anal pmid:19428213
Quintin J et al. Semisynthesis and antiproliferative evaluation of a series of 3'-aminoflavones. 2009 Bioorg. Med. Chem. Lett. pmid:19457664
Androutsopoulos VP et al. Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. 2009 BMC Cancer pmid:19531241
Yi LZ et al. Fingerprinting alterations of secondary metabolites of tangerine peels during growth by HPLC-DAD and chemometric methods. 2009 Anal. Chim. Acta pmid:19664461
Ionta M et al. Exogenous Cx43 expression decrease cell proliferation rate in rat hepatocarcinoma cells independently of functional gap junction. 2009 Cancer Cell Int. pmid:19678939
Zheng G et al. Simultaneous determination of five bioactive flavonoids in pericarpium Citri reticulatae from china by high-performance liquid chromatography with dual wavelength detection. 2009 J. Agric. Food Chem. pmid:19722565
Ishii K et al. Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells. 2010 Cancer Invest. pmid:19863351
Arafa el-SA et al. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. 2009 Cancer Res. pmid:19903849
Kandaswami C et al. Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. 1991 Cancer Lett. pmid:1998943
Lust S et al. The flavonoid tangeretin activates the unfolded protein response and synergizes with imatinib in the erythroleukemia cell line K562. 2010 Mol Nutr Food Res pmid:20077418
Walle T Methylation of dietary flavones increases their metabolic stability and chemopreventive effects. 2009 Int J Mol Sci pmid:20087474
Zou GA et al. Flavonoids from the stems of Croton caudatus Geisel. var. tomentosus Hook. 2010 Molecules pmid:20335965
Akachi T et al. Hepatoprotective effects of flavonoids from shekwasha (Citrus depressa) against D-galactosamine-induced liver injury in rats. 2010 J. Nutr. Sci. Vitaminol. pmid:20354348
Lewin G et al. Semisynthesis of natural flavones inhibiting tubulin polymerization, from hesperidin. 2010 J. Nat. Prod. pmid:20356063
Qiu P et al. Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells. 2010 Mol Nutr Food Res pmid:20397199
Stuetz W et al. Polymethoxylated flavones, flavanone glycosides, carotenoids, and antioxidants in different cultivation types of tangerines ( Citrus reticulata Blanco cv. Sainampueng) from Northern Thailand. 2010 J. Agric. Food Chem. pmid:20420369
Treutter D Managing phenol contents in crop plants by phytochemical farming and breeding-visions and constraints. 2010 Int J Mol Sci pmid:20479987
Yamanishi Y et al. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. 2010 Bioinformatics pmid:20529913
Asami Y et al. Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources. 2010 BMC Pharmacol. pmid:20537191